Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

NCT01084083 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

NETWORK

Sponsor class

Conditions

Head and Neck Cancer
Precancerous Condition

Interventions

BIOLOGICAL: cetuximab
RADIATION: intensity-modulated radiation therapy (IMRT)
DRUG: Paclitaxel
DRUG: Cisplatin

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]